Toxicological Profile for Trichloroethylene (TCE)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
This Table of Gas and Materials Compatibility
Materials Compatibility Section G – Technical Data Section G – Technical Gas Compatibility Directions The compatibility data shown on pages To use the compatibility chart on the 2 and 3 of this Section G have been following pages, proceed as follows: compiled to assist in evaluating ap- 1 3 propriate materials for use in handling various gases. It is extremely important Locate the gas you are using in the Refer to the applicable “Key to that all gas control equipment be com- first column of the chart. Materials Compatibility Symbol”. patible with the gas being used. The 2 4 use of a device that is not compatible Check the materials of construction Verify that the “Key to Materials may damage the unit and cause a leak you intend to use. Materials of Compatibility Symbol” allows this that could result in property damage Construction have been grouped by combination and that the application or personal injury. To reduce potentially metals, plastics and elastomers. is satisfactory. harmful situations, always check for the compatibility of equipment and materials before using any gases in Key to Materials Compatibility your gas control equipment. S – Satisfactory for use with the intended gas. Since combinations of gases are C – Conditional. May be incompatible under some circumstances or conditions. virtually unlimited, mixtures (except Contact your Praxair representative for additional information. for Oxyfume® and Medifume® steril- U – Unsatisfactory for use with the intended gas. izing gas mixtures) are not listed in the Compatibility Chart. Before using a I – Insufficient data available to determine compatibility with the gas mixture or any gas not listed in the intended gas. -
Rhode Island Hazardous Substance List
Rhode Island Hazardous Substance List Source: T - ACGIH F - NFPA49 C - IARC Alphabetical Order C.A.S. ACGIH NFPA IARC CHEMICAL NAME 13010-47-4 C 1,-(2-Chloroethyl)-3-cyclohexyl-1-Nitrosourea 76-11-9 T 1,1,1,2-tetrachloro-2,2-difluoroethane 76-12-0 T 1,1,2,2-tetrachloro-1,2-difluoroethane 79-34-5 T 1,1,2,2-tetrachloroethane - skin 76-13-1 T 1,1,2-trichloro-1,2,2-trifluoroethane 79-00-5 T F C 1,1,2-trichloroethane - skin 594-72-9 T 1,1-Dichloro-1-nitroethane 74-34-3 T 1,1-dichloroethane 57-14-7 T 1,1-dimethylhydrazine (udmh) 96-18-4 T 1,2,3-trichloropropane 120-82-1 T 1,2,4-Trichlorobenzene 106-88-7 F 1,2-Butylene oxide 107-15-3 T F 1,2-Diaminoethane 96-12-8 C 1,2-Dibromo-3-chloropropane 106-93-4 T F C 1,2-Dibromoethane - skin 107-06-2 T F 1,2-Dichlorethane 540-59-0 T F 1,2-Dichloroethene 540-59-0 T F 1,2-Dichloroetylene 1615-80-1 C 1,2-Diethylhydrazine C 1,2-Dimethyl hydrazine - skin 106-99-0 T F 1,3-Butadiene 118-52-5 T 1,3-Dichloro-5,5-dimethylhydantoin 542-75-6 T F 1,3-Dichloropropene (cis and trans) 542-75-6 T F 1,3-Dichloropropylene 110-56-5 F 1,4-Dichlorobutane 123-91-1 T F C 1,4-Dioxane 1120-71-4 1-3-Propane sultone 110-53-2 F 1-Bromopentane 106-89-8 T F C 1-Chloro,2,3-epoxy-propane 600-25-9 T 1-Chloro-1-nitropropane 97-00-7 F 1-chloro-2,4-dinitrobenzene 543-59-9 F 1-Chloropentane 112-30-1 F 1-Decanol 111-27-3 F 1-Hexanol 141-79-7 T F 1-Isobutenyl methyl ketone 108-03-2 T F 1-Nitropropane 71-41-0 F 1-Pentanol 110-58-7 F 1-Pentylamine 111-40-0 T F 2,2'-Diaminodiethylamine 111-44-4 F 2,2'Dichlorodiethyl ether 75-99-0 T 2,2-dichloropropionic acid 556-52-5 T 2,3-Epoxy-1-propanol 93-76-5 T 2,4,5-T 95-95-4 F 2,4,5-trichlorophenol 88-06-2 F C 2,4,6-trichlorophenol 118-96-7 T F 2,4,6-Trinitro Toluene 479-95-8 T 2,4,6-Trinitrophenyl-methylnitramine 94-75-7 T 2,4-d (2,4-dichlorophenoxyacetic acid) 97-02-9 F 2,4-dinitroaniline 584-84-9 T F 2,4-Tolylene diisocyanate 108-83-8 T 2,6-Dimethyl-4-heptanone 108-83-8 T 2,6-Dimethyl-4-heptanone 128-37-0 T 2,6-Ditert. -
Zinc, Magnesium and NMDA Receptor Alterations in the Hippocampus of Suicide Victims
Journal of Affective Disorders 151 (2013) 924–931 Contents lists available at ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims Magdalena Sowa-Kućma a,n, Bernadeta Szewczyk a, Krystyna Sadlik b, Wojciech Piekoszewski c,d, Franciszek Trela e,Włodzimierz Opoka f, Ewa Poleszak g, Andrzej Pilc a,h, Gabriel Nowak a,i a Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland b Institute of Forensic Research, Kraków, Poland c Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, Kraków, Poland d Laboratory of High Resolution Mass Spectrometry, Regional Laboratory of Physicochemical Analysis and Structural Research, Faculty of Chemistry, Jagiellonian University, Kraków, Poland e Department of Forensic Medicine, Jagiellonian University Medical College, Kraków, Poland f Department of Inorganic Chemistry, Jagiellonian University Medical College, Kraków, Poland g Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland h Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland i Chair of Pharmacobiology, Jagiellonian University Medical College, Kraków, Poland article info abstract Article history: Background: There is evidence for an association between suicidal behavior and depression. Accumulat- Received 27 May 2013 ing data suggests that depression is related to a dysfunction of the brain's glutamatergic system, and that Received in revised form the N-methyl-D-aspartate (NMDA) receptor plays an important role in antidepressant activity. Zinc and 9 August 2013 magnesium, the potent antagonists of the NMDA receptor complex, are involved in the pathophysiology Accepted 9 August 2013 of depression and exhibit antidepressant activity. -
Dichloroethylene
Development Support Document Final, October 15, 2007 Accessible 2013 1,1-Dichloroethylene CAS Registry Number: 75-35-4 Prepared by Shannon Ethridge, M.S. Toxicology Section Chief Engineer’s Office ___________________________________________________________ TEXAS COMMISSION ON ENVIRONMENTAL QUALITY 1,1 Dichloroethylene Page 2 TABLE OF CONTENTS CHAPTER 1 SUMMARY TABLES ........................................................................................... 4 CHAPTER 2 MAJOR USES OR SOURCES ............................................................................ 6 CHAPTER 3 ACUTE EVALUATION ....................................................................................... 6 3.1 HEALTH-BASED ACUTE REV AND ESL ................................................................................. 6 3.1.1 Physical/Chemical Properties and Key Studies ............................................................. 6 3.1.2 Mode-of-Action (MOA) Analysis ................................................................................. 10 3.1.3 Dose Metric .................................................................................................................. 10 3.1.4 Point of Departure (POD) for the Key Study............................................................... 10 3.1.5 Dosimetric Adjustments ............................................................................................... 11 3.1.6 Critical Effect and Adjustment of PODHEC .................................................................. 11 3.1.7 Health-Based -
Pharmacology – Inhalant Anesthetics
Pharmacology- Inhalant Anesthetics Lyon Lee DVM PhD DACVA Introduction • Maintenance of general anesthesia is primarily carried out using inhalation anesthetics, although intravenous anesthetics may be used for short procedures. • Inhalation anesthetics provide quicker changes of anesthetic depth than injectable anesthetics, and reversal of central nervous depression is more readily achieved, explaining for its popularity in prolonged anesthesia (less risk of overdosing, less accumulation and quicker recovery) (see table 1) Table 1. Comparison of inhalant and injectable anesthetics Inhalant Technique Injectable Technique Expensive Equipment Cheap (needles, syringes) Patent Airway and high O2 Not necessarily Better control of anesthetic depth Once given, suffer the consequences Ease of elimination (ventilation) Only through metabolism & Excretion Pollution No • Commonly administered inhalant anesthetics include volatile liquids such as isoflurane, halothane, sevoflurane and desflurane, and inorganic gas, nitrous oxide (N2O). Except N2O, these volatile anesthetics are chemically ‘halogenated hydrocarbons’ and all are closely related. • Physical characteristics of volatile anesthetics govern their clinical effects and practicality associated with their use. Table 2. Physical characteristics of some volatile anesthetic agents. (MAC is for man) Name partition coefficient. boiling point MAC % blood /gas oil/gas (deg=C) Nitrous oxide 0.47 1.4 -89 105 Cyclopropane 0.55 11.5 -34 9.2 Halothane 2.4 220 50.2 0.75 Methoxyflurane 11.0 950 104.7 0.2 Enflurane 1.9 98 56.5 1.68 Isoflurane 1.4 97 48.5 1.15 Sevoflurane 0.6 53 58.5 2.5 Desflurane 0.42 18.7 25 5.72 Diethyl ether 12 65 34.6 1.92 Chloroform 8 400 61.2 0.77 Trichloroethylene 9 714 86.7 0.23 • The volatile anesthetics are administered as vapors after their evaporization in devices known as vaporizers. -
Health Effects Support Document for Hexachlorobutadiene Health Effects Support Document for Hexachlorobutadiene
Health Effects Support Document for Hexachlorobutadiene Health Effects Support Document for Hexachlorobutadiene U.S. Environmental Protection Agency Office of Water (4304T) Health and Ecological Criteria Division Washington, DC 20460 www.epa.gov/safewater/ EPA 822-R-03-002 February 2003 Printed on Recycled Paper FOREWORD The Safe Drinking Water Act (SDWA), as amended in 1996, requires the Administrator of the Environmental Protection Agency (EPA) to establish a list of contaminants to aid the agency in regulatory priority setting for the drinking water program. In addition, SDWA requires EPA to make regulatory determinations for no fewer than five contaminants by August 2001. The criteria used to determine whether or not to regulate a chemical on the CCL are the following: The contaminant may have an adverse effect on the health of persons. The contaminant is known to occur or there is a substantial likelihood that the contaminant will occur in public water systems with a frequency and at levels of public health concern. In the sole judgment of the administrator, regulation of such contaminant presents a meaningful opportunity for health risk reduction for persons served by public water systems. The Agency’s findings for the three criteria are used in making a determination to regulate a contaminant. The Agency may determine that there is no need for regulation when a contaminant fails to meet one of the criteria. This document provides the health effects basis for the regulatory determination for hexachlorobutadiene. In arriving at the regulatory determination, data on toxicokinetics, human exposure, acute and chronic toxicity to animals and humans, epidemiology, and mechanisms of toxicity were evaluated. -
(12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al
USOO8603526B2 (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen et al. (45) Date of Patent: Dec. 10, 2013 (54) PHARMACEUTICAL COMPOSITIONS 2008. O152595 A1 6/2008 Emigh et al. RESISTANT TO ABUSE 2008. O166407 A1 7/2008 Shalaby et al. 2008/0299.199 A1 12/2008 Bar-Shalom et al. 2008/0311205 A1 12/2008 Habib et al. (75) Inventors: Peter Holm Tygesen, Smoerum (DK); 2009/0022790 A1 1/2009 Flath et al. Jan Martin Oevergaard, Frederikssund 2010/0203129 A1 8/2010 Andersen et al. (DK); Karsten Lindhardt, Haslev (DK); 2010/0204259 A1 8/2010 Tygesen et al. Louise Inoka Lyhne-versen, Gentofte 2010/0239667 A1 9/2010 Hemmingsen et al. (DK); Martin Rex Olsen, Holbaek 2010, O291205 A1 11/2010 Downie et al. (DK); Anne-Mette Haahr, Birkeroed 2011 O159100 A1 6/2011 Andersen et al. (DK); Jacob Aas Hoellund-Jensen, FOREIGN PATENT DOCUMENTS Frederikssund (DK); Pemille Kristine Hoeyrup Hemmingsen, Bagsvaerd DE 20 2006 014131 1, 2007 (DK) EP O435,726 8, 1991 EP O493513 7, 1992 EP O406315 11, 1992 (73) Assignee: Egalet Ltd., London (GB) EP 1213014 6, 2002 WO WO 89,09066 10, 1989 (*) Notice: Subject to any disclaimer, the term of this WO WO91,040 15 4f1991 patent is extended or adjusted under 35 WO WO95/22962 8, 1995 U.S.C. 154(b) by 489 days. WO WO99,51208 10, 1999 WO WOOOf 41704 T 2000 WO WO 03/024426 3, 2003 (21) Appl. No.: 12/701,429 WO WOO3,O24429 3, 2003 WO WOO3,O24430 3, 2003 (22) Filed: Feb. -
1,1,1-Trichloroethane (CASRN 71-55-6) | IRIS
Integrated Risk Information System (IRIS) U.S. Environmental Protection Agency Chemical Assessment Summary National Center for Environmental Assessment 1,1,1-Trichloroethane; CASRN 71-55-6 Human health assessment information on a chemical substance is included in the IRIS database only after a comprehensive review of toxicity data, as outlined in the IRIS assessment development process. Sections I (Health Hazard Assessments for Noncarcinogenic Effects) and II (Carcinogenicity Assessment for Lifetime Exposure) present the conclusions that were reached during the assessment development process. Supporting information and explanations of the methods used to derive the values given in IRIS are provided in the guidance documents located on the IRIS website. STATUS OF DATA FOR 1,1,1-Trichloroethane File First On-Line 03/31/1987 Category (section) Assessment Available? Last Revised Oral RfD (I.A.) Acute Oral RfD (I.A.1.) qualitative discussion 09/28/2007 Short-term Oral RfD (I.A.2.) qualitative discussion 09/28/2007 Subchronic Oral RfD (I.A.3.) yes 09/28/2007 Chronic Oral RfD (I.A.4.) yes 09/28/2007 Inhalation RfC (I.B.) Acute Inhalation RfC (I.B.1.) yes 09/28/2007 Short-term Inhalation RfC (I.B.2.) yes 09/28/2007 Subchronic Inhalation RfC (I.B.3.) yes 09/28/2007 1 Integrated Risk Information System (IRIS) U.S. Environmental Protection Agency Chemical Assessment Summary National Center for Environmental Assessment Category (section) Assessment Available? Last Revised Chronic Inhalation RfC (I.B.4.) yes 09/28/2007 Carcinogenicity Assessment (II.) yes 09/28/2007 I. Health Hazard Assessments for Noncarcinogenic Effects I.A. -
Zinc-Magnesium Supplementation, Hormones and Strength
Zinc-Magnesium Supplementation, Hormones and Strength JEPonline Journal of Exercise Physiologyonline Official Journal of The American Society of Exercise Physiologists (ASEP) ISSN 1097-9751 An International Electronic Journal Volume 3 Number 4 October 2000 Exercise Nutrition Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength L.R. BRILLA1 AND VICTOR CONTE2 1Exercise and Sports Science Laboratory, Western Washington University, Bellingham, WA 98225-9067 and 2BALCO Laboratories, 1520 Gilbreth Road, Burlingame, CA 94010, Tel: 800-777-7122 L.R. BRILLA AND VICTOR CONTE. Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength. JEPonline, 3(4): 26-36, 2000. Muscle attributes and selected blood hormones of football players were assessed in response to a nightly supplementation regimen during spring football, over an 8-week period, with pre-post measures. A double-blind randomized study was conducted with ZMA (30 mg zinc monomethionine aspartate, 450 mg magnesium aspartate, and 10.5 mg of vitamin B-6) and placebo (P), n=12 and n=15, respectively. Plasma zinc and magnesium levels were ZMA (0.80 to 1.04 mg/ml; 19.43 to 20.63 mcg/ml ) and P (0.84 to 0.80 mg/ml ; 19.68 to 18.04 mg/ml), respectively (P<0.001). Free testosterone increased with ZMA (132.1 to 176.3 pg/mL), compared to P (141.0 to 126.6 pg/mL) (P<0.001); IGF-I increased in the ZMA group (424.2 to 439.3 ng/mL) and decreased in P (437.3 to 343.3 ng/mL) (P<0.001). -
Nicotine Induces Polyspermy in Sea Urchin Eggs Through a Non-Cholinergic Pathway Modulating Actin Dynamics
cells Article Nicotine Induces Polyspermy in Sea Urchin Eggs through a Non-Cholinergic Pathway Modulating Actin Dynamics 1,2 1, 2 1, Nunzia Limatola , Filip Vasilev y, Luigia Santella and Jong Tai Chun * 1 Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, I-80121 Napoli, Italy; [email protected] (N.L.); [email protected] (F.V.) 2 Department of Research Infrastructures for Marine Biological Resources, Stazione Zoologica Anton Dohrn, I-80121 Napoli, Italy; [email protected] * Correspondence: [email protected] Current address: Centre de Recherche du Centre Hospitalier de l’Université de Montreal (CRCHUM) y Montreal, QC H2X 0A9, Canada. Received: 8 November 2019; Accepted: 21 December 2019; Published: 25 December 2019 Abstract: While alkaloids often exert unique pharmacological effects on animal cells, exposure of sea urchin eggs to nicotine causes polyspermy at fertilization in a dose-dependent manner. Here, we studied molecular mechanisms underlying the phenomenon. Although nicotine is an agonist of ionotropic acetylcholine receptors, we found that nicotine-induced polyspermy was neither mimicked by acetylcholine and carbachol nor inhibited by specific antagonists of nicotinic acetylcholine receptors. Unlike acetylcholine and carbachol, nicotine uniquely induced drastic rearrangement of egg cortical microfilaments in a dose-dependent way. Such cytoskeletal changes appeared to render the eggs more receptive to sperm, as judged by the significant alleviation of polyspermy by latrunculin-A and mycalolide-B. In addition, our fluorimetric assay provided the first evidence that nicotine directly accelerates polymerization kinetics of G-actin and attenuates depolymerization of preassembled F-actin. Furthermore, nicotine inhibited cofilin-induced disassembly of F-actin. -
Toxicological Profile for 1,1-Dichloroethene Draft for Public Comment December 2019 1,1-DICHLOROETHENE Ii
F Toxicological Profile for 1,1-Dichloroethene Draft for Public Comment December 2019 1,1-DICHLOROETHENE ii DISCLAIMER Use of trade names is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services. This information is distributed solely for the purpose of pre dissemination public comment under applicable information quality guidelines. It has not been formally disseminated by the Agency for Toxic Substances and Disease Registry. It does not represent and should not be construed to represent any agency determination or policy. ***DRAFT FOR PUBLIC COMMENT*** 1,1-DICHLOROETHENE iii FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for these toxic substances described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced. The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile begins with a relevance to public health discussion which would allow a public health professional to make a real-time determination of whether the presence of a particular substance in the environment poses a potential threat to human health. -
Photocatalytic Bleaching of Evans Blue Over Zinc Oxide Particulate
Indian Journal of Chemistry Vol. 46A, March 2007, pp. 432-435 8 Photocatalytic bleaching of Evans blue over Matsuo and Udea have used SrTiO3-TiO2 composite zinc oxide particulate system powder for the photocatalytic bleaching of methylene blue. Preparation and characterization of ZnO/TiO2, Sharad Kothari*, Preeti Ameta & Rameshwar Ameta photocatalyst and their photocatalytic activity were reported by Liao et al.9 PG Department of Chemistry, Government College, 10,11 Banswara 327 001, India Sehili et al. have investigated the photocatalytic Email: [email protected] transformation of chloroaromatic derivatives such as Received 10 May 2006; revised 31 January 2007 chlorophenol and dichlorobenzenes on ZnO involving the formation of an adduct between OH• radicals and Evans blue, an azo dye, and its mixture with amaranth are 12 degraded photocatalytically in presence of zinc oxide. The aromatic compound. Driessen et al. have studied optimum conditions for photobleaching of these dyes, like surface band(CB) and gas phase products and concentration of dye, pH, amount of semiconductor, light intermediates with FT-IR spectroscopy during intensity, etc., have been studied. During the photocatalytic photocatalytic oxidation of trichloroethylene on ZnO. degradation, the semiconductor (ZnO) remains unaffected as Synthesis and photocatalytic activity of ZnO/ZrO2 evident from its FT-IR. The studied dyes are commonly used in 13 dyeing, printing and textile industries and hence, the present work composite have been reported by Hsu and Wu. Riaj will be helpful in the treatment of coloured effluents from these et al.14 used ZnO as a photocatalyst for the industries. photocatalytic bleaching of rhodamine-6G. 8 Photocatalytic bleaching of Evan blue (EB) has not IPC Code: Int.